| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |